Latest Breaking News On - American glaucoma society - Page 15 : comparemela.com
Nicox Appoints Robert N Weinreb, M D and Sanjay G Asrani, M D to its Glaucoma Clinical Advisory Board
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Operator
Welcome to Glaukos Corporation s First Quarter 2021 Financial Results Conference Call. A copy of the company s press release issued after the market close today is available at www.glaukos.com or http://www.glaukos.com. [Operator Instructions] This call is being recorded and an archived replay will be available online in the Investor Relations section at www.glaukos.com or http://www.glaukos.com.
I will now turn the call over to Chris Lewis, Senior Director of Investor Relations and Corporate Strategy and Development.
Chris Lewis
Senior Director, Investor Relations, Corporate Strategy and Development
Thank you, and good afternoon. Joining me today are Glaukos President and CEO, Tom Burns; CFO, Joe Gilliam; and COO, Chris Calcaterra. Following our prepared remarks, we ll open the call to questions. To ensure ample time and opportunity to address everyone s questions, we request that you limit yourself to one question and one follow-up. If you still have additional que
Share this article
Share this article
NEW YORK, April 15, 2021 /PRNewswire/ Edwin M. Schottenstein, MD, FACS, is being recognized by Continental Who s Who for a Lifetime Achievement Award in Ophthalmology and his exemplary contributions in the medical field.
Edwin M. Schottenstein
Having led an outstanding medical career for over 40 years, Dr. Edwin M. Schottenstein is renowned as one of New York City s top board-certified ophthalmologists. He has garnered a commendable reputation for providing compassionate and thorough care for his patients. His attention to detail and willingness to spend the extra time with patients to resolve their needs is the guiding principle of his entire staff, and truly sets his practice apart from other New York City ophthalmologists.
Hydrus Microstent Now First MIGS Device Proven With 5-Year Pivotal Trial Data; Results Show Over 60% Reduction in Secondary Glaucoma Surgeries, Sustained Reduction in Medication Use
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Credit: Thomas Johnson and Johns Hopkins Medicine
In experiments in mouse tissues and human cells, Johns Hopkins Medicine researchers say they have found that removing a membrane that lines the back of the eye may improve the success rate for regrowing nerve cells damaged by blinding diseases. The findings are specifically aimed at discovering new ways to reverse vision loss caused by glaucoma and other diseases that affect the optic nerve, the information highway from the eye to the brain. The idea of restoring vision to someone who has lost it from optic nerve disease has been considered science fiction for decades. But in the last five years, stem cell biology has reached a point where it s feasible, says Thomas Johnson, M.D., Ph.D., assistant professor of ophthalmology at the Wilmer Eye Institute at the Johns Hopkins University School of Medicine.
vimarsana © 2020. All Rights Reserved.